Octapharma to invest in research and development in Vienna

Octapharma is currently constructing a new barrier-free low-energy building in Vienna with initial construction costs summing up to 13.5 million euros. It will house 13 labs and 39 offices for R&D and clinical research. Until the end of the year, the family-owned biopharmaceutical company will hire some 70 highly skilled people.

Sorry, this entry is only available in German!

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)lisavienna.at.